Insider · CIK 0001938678
Eric A Hughes
Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD), GLUE (Monte Rosa Therapeutics, Inc.). First filing Mar 5, 2025, latest Aug 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TEVA: TEVA PHARMACEUTICAL INDUSTRIES LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | $799k 52,742 shares | -100% | +20% from low-32% from high | |
| 30Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | $367k 23,251 shares | -100% | - | |
| 31Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | $400k 24,900 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +52,742 | - | - | 52,742 | Aug 5, 2025 |
| Aug 1, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -52,742 | $15.16 | $799k | 0 | Aug 5, 2025 |
| Aug 1, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -52,742 | $0.00 | $0 | 52,744 | Aug 5, 2025 |
| Jun 13, 2025 | GLUE Monte Rosa Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,700 | $0.00 | $0 | 30,700 | Jun 16, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | AGrant or award Restricted Share Unitsderivative | +78,616 | $0.00 | $0 | 78,616 | Mar 7, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +23,251 | - | - | 23,251 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -15,174 | $15.73 | $239k | 8,077 | Mar 6, 2025 |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -8,077 | $15.91 | $129k | 0 | Mar 6, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -23,251 | $0.00 | $0 | 69,754 | Mar 6, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Ordinary Shares10b5-1 | +24,900 | - | - | 24,900 | Mar 5, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -19,726 | $16.19 | $319k | 5,174 | Mar 5, 2025 |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SOpen-market sale Ordinary Shares10b5-1 | -5,174 | $15.56 | $80k | 0 | Mar 5, 2025 |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | MOption exercise Restricted Share Unitsderivative10b5-1 | -24,900 | $0.00 | $0 | 49,801 | Mar 5, 2025 |
| Dec 11, 2024 | GLUE Monte Rosa Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +44,200 | $0.00 | $0 | 44,200 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.